Evidence map›Paper›PMID 41911253›Full record

ArticlePloS one2026

Assessment of miRNAs as transcriptional regulators in respiratory syncytial virus infection through computational analysis and molecular docking studies.

Mubashir Hassan, Muhammad Shahzad Iqbal, Muhammad Yasir, Wanjoo Chun, Zainab Yaseen, Saba Shahzadi, Mark E Peeples, Andrzej Kloczkowski

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mubashir HassanThe Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, Ohio, United States of America.ORCID https://orcid.org/0009-0003-0054-0939
Muhammad Shahzad IqbalDepartment of Biochemistry, University of Okara, Okara, Pakistan.
Muhammad YasirDepartment of Pharmacology, Kangwon National University School of Medicine, Chuncheon, Republic of Korea.
Wanjoo ChunDepartment of Pharmacology, Kangwon National University School of Medicine, Chuncheon, Republic of Korea.ORCID https://orcid.org/0000-0003-1984-3545
Zainab YaseenDepartment of Biotechnology, Faculty of Science and Technology (FOST), University of Central Punjab, Lahore, Pakistan.
Saba ShahzadiThe Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, Ohio, United States of America.
Mark E PeeplesCenter for Vaccines and Immunity, Abigail Wexner Research Institute, Columbus, Ohio, United States of America.ORCID https://orcid.org/0000-0002-4582-317X
Andrzej KloczkowskiThe Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, Ohio, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globally, RSV is a major contributor to severe lower respiratory tract infections among children. Despite the significant medical concern posed by RSV, efforts to develop effective vaccines and antiviral drugs have largely fallen short, with the exception of immune prophylaxis available only for specific high-risk infants. We employed a suite of computational tools to investigate the role of microRNAs in the host's response to RSV infection. miRanda and RNAHybrid were instrumental in predicting microRNA-mRNA binding sites. For a deeper structural analysis, MC-Fold and MC-Sym were used to predict the 3D structures of both the miRNAs and their target mRNAs. The interactions between these molecules were then studied through RNA-RNA docking, with the resulting poses evaluated based on binding affinities and interaction profiles. This analysis focused on twelve selected miRNAs and their binding to specific sites on RSV mRNA. Finally, molecular dynamics (MD) simulations were conducted to evaluate the stability of the docked complexes. Taken together, these results suggest that two miRNAs, hsa_miR-2278 and hsa_miR-6732-3p, could potentially regulate the transcriptional activity during RSV infection and may warrant consideration as therapeutic agents.

Indexed as

MicroRNAsMolecular Docking SimulationRespiratory Syncytial VirusesRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsTranscription, GeneticBinding SitesComputational BiologyHumansMolecular Dynamics SimulationRNA, MessengerMicroRNAsRNA, Messenger

Identifiers

PMID41911253
PMCPMC13035128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.